- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01287403
Response of Alkylresorcinols to Different Cereals
August 2, 2018 updated by: CDUuser, Nestlé
Response of Alkylresorcinols and Other Biomarkers to Different Cereals
Cereal grains contain a wide variety of different phytochemicals which may play different roles in physiology.
Their response in plasma and urine after a meal is poorly defined for most cereals.
This study will investigate the plasma response and urinary excretion of cereal compounds after eating 6 different types of cereal preparation, with a focus on alkylresorcinols.
Study Overview
Status
Completed
Conditions
Detailed Description
This was a cross-over, randomized, double blind study with 6 arms (flours of different composition).
Thirteen subjects completed the trial, where 100 g of each flour, mixed with 300 mL milk, was fed to all subjects.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1000
- NESTEC / Clinical Development Unit / Metabolic Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy
- Normal-overweight (BMI 19-28 kg/m2)
- Non-smokers
Exclusion Criteria:
- Regular consumers of wholegrain cereals
- Allergy to cereal or milk products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Refined wheat flour
A negative control flour to serve as a reference.
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
ACTIVE_COMPARATOR: Esterase wholegrain wheat flour
Wholegrain wheat flour treated with esterases to release phenolics (positive control for phenolic acids)
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
EXPERIMENTAL: Wholegrain wheat flour
Flour with unknown response
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
EXPERIMENTAL: Liquid whole grain wheat flour
Test flour with unknown response.
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
EXPERIMENTAL: Wholegrain barley flour
Test flour with unknown response.
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
EXPERIMENTAL: Liquid wholegrain barley flour
Test flour with unknown response.
|
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
A treated cereal flour mixed with milk.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma Alkylresorcinol Compounds
Time Frame: From 0 to 48 h post dose.
|
Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms.
Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.
|
From 0 to 48 h post dose.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma and Urinary Betaine
Time Frame: From 0 to 48 hours post dose
|
From 0 to 48 hours post dose
|
|
Phenolic Acids
Time Frame: 0-48 h post dose
|
Phenolic acids in plasma and urine
|
0-48 h post dose
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Alastair B Ross, PhD, Nestlé
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (ACTUAL)
August 1, 2012
Study Completion (ACTUAL)
December 1, 2012
Study Registration Dates
First Submitted
January 30, 2011
First Submitted That Met QC Criteria
January 31, 2011
First Posted (ESTIMATE)
February 1, 2011
Study Record Updates
Last Update Posted (ACTUAL)
August 31, 2018
Last Update Submitted That Met QC Criteria
August 2, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 10.14 MET
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Esterase wholegrain wheat flour
-
University of CopenhagenLantmännens ForskningsstiftelseUnknownGastrointestinal Diseases | Cardiovascular Diseases | Obesity
-
University of CopenhagenBARILLA G. e R. Fratelli S.p.A., Parma, Italy; the European Commission in the...Completed
-
Purdue UniversityCompletedObesity | Diabetes Mellitus, Type 2 | Appetitive BehaviorUnited States
-
Swedish University of Agricultural SciencesCompleted
-
University of Maryland, BaltimoreCompletedSchizophreniaUnited States
-
University of PalermoRecruitingNon-celiac Wheat SensitivityItaly
-
University of PalermoRecruiting
-
Peking UniversityCompleted
-
University of PalermoCompletedFamilial Mediterranean Fever (FMF) | Not-celiac Wheat Sensitivity (NCWS)Italy
-
Peking UniversityNot yet recruitingChronic Disease PreventionChina